Sarah E Nash
CIK 1345709 · Executive Chair & Interim CEO · last filed 2026-06-15
Sarah E Nash is an Executive Chair & Interim CEO who has filed 115 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for BBWI, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$5.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.7M across reported positions. 22 SEC filings were submitted jointly with Bath & Body Works, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BBWI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
COLUMBUS, OH 43230
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBWI | Director | 298,894 | $19.84 | $5.93M | -$2.79M | 14 | 2026-06-15 |
| BLKB | Director | 22,123 | $53.24 | $1.18M | -$2.11M | 51 | 2024-11-21 |
| LB | Director | 32,211 | $80.05 | $2.58M | $0 | 6 | 2021-07-12 |
| KNOLL INC (KNL) Delisted | Director | 40,101 | $25.04 | $1.00M | -$736.4K | 31 | 2021-07-01 |
| MERRIMACK PHARMACEUTICALS INC (MACK) Delisted | Director | 189,943 | $15.13 | $2.87M | $198.3K | 4 | 2013-12-04 |
| PATHMARK STORES INC (PTMKW) Delisted | Director | 0 | — | — | $0 | 2 | 2007-12-04 |
Recent Filings
115 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | BBWI | Grant (A) | +13,284 | $0 | EDGAR |
| 2025-11-25 | BBWI | Buy (P) | +10,000 | $155.8K | EDGAR |
| 2025-06-09 | BBWI | Grant (A) | +9,402 | $0 | EDGAR |
| 2025-03-12 | BBWI | Mixed | +110,512 | -$511.0K | EDGAR |
| 2024-11-21 | BLKB | Sell (S) | −1,600 | -$133.5K | EDGAR |
| 2024-11-13 | BLKB | Sell (S) | −3,100 | -$260.3K | EDGAR |
| 2024-08-09 | BLKB | Sell (S) | −3,220 | -$245.3K | EDGAR |
| 2024-08-08 | BLKB | Notice (144) | −3,220 | -$245.3K | EDGAR |
| 2024-08-02 | BLKB | Grant (A) | +3,066 | $0 | EDGAR |
| 2024-06-28 | BBWI | Grant (A) | +6,406 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.